Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
Adv Ther ; 39(1): 674-691, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34853985

RESUMO

INTRODUCTION: This long-term post-marketing surveillance (SAPPHIRE) collected information on the safety and effectiveness of canagliflozin (approved dose 100 mg) prescribed to patients with type 2 diabetes mellitus (T2DM) in real-world practice in Japan. METHODS: Patients with T2DM who were prescribed canagliflozin between December 2014 and September 2016 were registered and observed for up to 3 years. Safety was evaluated in terms of adverse drug reactions (ADRs). Effectiveness was assessed in terms of glycaemic control. Data were also analysed across age subgroups (< 65, ≥ 65 to < 75, and ≥ 75 years old) and the estimated glomerular filtration rate (eGFR) categories for chronic kidney disease (G1-G5 based on eGFR) at baseline. RESULTS: A total of 12,227 patients were included in the safety analyses and 11,675 in effectiveness analyses. Overall, 7104 patients were treated with canagliflozin for ≥ 3 years. The mean age, haemoglobin A1c (HbA1c), and eGFR at baseline were 58.4 ± 12.5 years, 8.01 ± 1.49%, and 80.04 ± 21.85 mL/min/1.73 m2, respectively. There were 1836 ADRs in 1312 patients (10.73%) and 268 serious ADRs in 225 patients (1.84%). The most common ADRs were those related to volume depletion (1.39%), genital infection (1.34%), polyuria/pollakiuria (1.23%), and urinary tract infection (1.19%). The frequencies of ADRs tended to increase with age and stage of chronic kidney disease. The reductions in mean HbA1c after starting canagliflozin were maintained for up to 3 years with a mean change of - 0.68% (n = 6345 at 3 years). Maintained reductions in mean HbA1c were observed in each age subgroup and in patients with G1-G3b renal function. CONCLUSION: This surveillance in real-world clinical practice showed that canagliflozin provides sustained glucose-lowering effects in patients with T2DM, including elderly patients and patients with moderate renal impairment, without new safety concerns beyond those already described in the Japanese package insert. TRIAL REGISTRATION: JapicCTI-153048.


Canagliflozin is a sodium­glucose cotransporter 2 (SGLT2) inhibitor that lowers blood glucose levels by increasing urinary glucose excretion. It was approved for the management of blood glucose levels in patients with type 2 diabetes mellitus following clinical trials. However, clinical trials may not fully represent the safety or effectiveness of a drug in real-world clinical practice. Therefore, a 3-year post-marketing surveillance was performed in Japan to obtain safety and effectiveness data for a large group of 12,227 patients with type 2 diabetes mellitus and various demographic/clinical characteristics. Safety and effectiveness data were collected for up to 3 years while patients were treated with canagliflozin. Adverse drug reactions occurred in 10.73% of patients. The most common types of adverse drug reactions were those related to volume depletion (body fluid decreased), followed by genital infection, polyuria/pollakiuria (increased urination), and urinary tract infection. Adverse drug reactions tended to be more common in elderly patients and in patients with renal impairment. As expected, canagliflozin was associated with improvements in haemoglobin A1c, a marker of blood glucose control, in patients with type 2 diabetes, including in elderly patients and patients with moderate renal impairment. In this surveillance in real-world clinical practice, long-term treatment with canagliflozin raised no new safety concerns beyond the information already included in the Japanese package insert. Canagliflozin provides sustained glucose-lowering effects.


Assuntos
Canagliflozina , Diabetes Mellitus Tipo 2 , Idoso , Óxido de Alumínio/uso terapêutico , Glicemia , Canagliflozina/efeitos adversos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/epidemiologia , Hemoglobinas Glicadas/análise , Humanos , Hipoglicemiantes/efeitos adversos , Japão/epidemiologia , Vigilância de Produtos Comercializados , Resultado do Tratamento
2.
Nephrol Dial Transplant ; 37(8): 1461-1471, 2022 07 26.
Artigo em Inglês | MEDLINE | ID: mdl-34383954

RESUMO

BACKGROUND: Verinurad is a human uric acid (UA) transporter (URAT1) inhibitor known to decrease serum UA (sUA) levels and that may reduce albuminuria. In a Phase 2a study (NCT03118739), treatment with verinurad + febuxostat lowered urine albumin-to-creatinine ratio (UACR) at 12 weeks by 39% (90% confidence interval 4-62%) among patients with Type 2 diabetes mellitus, hyperuricaemia and albuminuria. The Phase 2b, randomized, placebo-controlled Study of verinurAd and alloPurinol in Patients with cHronic kIdney disease and hyperuRicaEmia (SAPPHIRE; NCT03990363) will examine the effect of verinurad + allopurinol on albuminuria and estimated glomerular filtration rate (eGFR) slope among patients with chronic kidney disease (CKD) and hyperuricaemia. METHODS: Adults (≥18 years of age) with CKD, eGFR ≥25 mL/min/1.73 m2, UACR 30-5000 mg/g and sUA ≥6.0 mg/dL will be enrolled. Approximately 725 patients will be randomized 1:1:1:1:1 to 12, 7.5 or 3 mg verinurad + allopurinol, allopurinol or placebo. An 8-week dose-titration period will precede a 12-month treatment period; verinurad dose will be increased to 24 mg at Month 9 in a subset of patients in the 3 mg verinurad + allopurinol arm. The primary efficacy endpoint the is change from baseline in UACR at 6 months. Secondary efficacy endpoints include changes in UACR, eGFR and sUA from baseline at 6 and 12 months. CONCLUSIONS: This study will assess the combined clinical effect of verinurad + allopurinol on kidney function in patients with CKD, hyperuricaemia and albuminuria, and whether this combination confers renoprotection beyond standard-of-care.


Assuntos
Diabetes Mellitus Tipo 2 , Hiperuricemia , Insuficiência Renal Crônica , Adulto , Albuminúria/complicações , Alopurinol/uso terapêutico , Óxido de Alumínio/farmacologia , Óxido de Alumínio/uso terapêutico , Ensaios Clínicos Fase II como Assunto , Demografia , Diabetes Mellitus Tipo 2/complicações , Taxa de Filtração Glomerular , Humanos , Hiperuricemia/tratamento farmacológico , Hiperuricemia/etiologia , Naftalenos , Propionatos , Piridinas , Ensaios Clínicos Controlados Aleatórios como Assunto , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/tratamento farmacológico
3.
Exp Dermatol ; 28(2): 169-176, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30566262

RESUMO

Boehmite (γ-AlOOH) has a wide range of applications in a variety of industrial and biological fields. However, little is known about its potential roles in skin diseases. The current study investigated its effect on atopic dermatitis (AD). Following characterization, cytotoxicity, pro-inflammatory response and oxidative stress associated with boehmite were assessed, using TNF-α-induced keratinocytes and mast cells. In addition, therapeutic effects of boehmite, topically administered to Balb/c mice induced by 2,4-dinitrochlorobenzene (DNCB), were evaluated. Expression of cytokines (TLSP, IL-25 and IL-33) and the generation of ROS from keratinocytes induced by TNF-α were significantly inhibited by boehmite without affecting cell viability. MAPKs (ERK, JNK and p38) required for cytokine expression were suppressed by boehmite treatment. Up-regulation of cytokines (TSLP, IL-4, IL-5, IL-13, RANTES) in human mast cells treated with phorbol 12-myristate 13-acetate and calcium ionophore was also suppressed by boehmite. Boehmite improved the AD severity score, epidermal hyperplasia and transepidermal water loss in DNCB-induced AD-like lesions. Moreover, Th2-mediated cytokine expression, mast cell hyperplasia and destruction of the skin barrier were improved by boehmite treatment. Overall, we demonstrated that boehmite may potentially protect against AD.


Assuntos
Hidróxido de Alumínio/uso terapêutico , Óxido de Alumínio/uso terapêutico , Dermatite Atópica/tratamento farmacológico , Dermatopatias/tratamento farmacológico , Pele/efeitos dos fármacos , Administração Tópica , Animais , Anti-Inflamatórios/uso terapêutico , Linhagem Celular Tumoral , Sobrevivência Celular , Dinitroclorobenzeno , Epiderme/metabolismo , Humanos , Inflamação , Interleucina-33/metabolismo , Interleucinas/metabolismo , Queratinócitos/citologia , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Estresse Oxidativo , Serina Endopeptidases/metabolismo , Acetato de Tetradecanoilforbol , Fator de Necrose Tumoral alfa/metabolismo
4.
Bioconjug Chem ; 29(3): 786-794, 2018 03 21.
Artigo em Inglês | MEDLINE | ID: mdl-29382195

RESUMO

A simple and effective strategy was developed to enrich ubiquitinated proteins (UPs) from cancer cell lysate using the α-Al2O3 nanoparticles covalently linked with ubiquitin binding protein (Vx3) (denoted as α-Al2O3-Vx3) via a chemical linker. The functionalized α-Al2O3-Vx3 showed long-term stability and high efficiency for the enrichment of UPs from cancer cell lysates. Flow cytometry analysis results indicated dendritic cells (DCs) could more effectively phagocytize the covalently linked α-Al2O3-Vx3-UPs than the physical mixture of α-Al2O3 and Vx3-UPs (α-Al2O3/Vx3-UPs). Laser confocal microscopy images revealed that α-Al2O3-Vx3-UPs localized within the autophagosome of DCs, which then cross-presented α-Al2O3-Vx3-UPs to CD8+ T cells in an autophagosome-related cross-presentation pathway. Furthermore, α-Al2O3-Vx3-UPs enhanced more potent antitumor immune response and antitumor efficacy than α-Al2O3/cell lysate or α-Al2O3/Vx3-UPs. This work highlights the potential of using the Vx3 covalently linked α-Al2O3 as a simple and effective platform to enrich UPs from cancer cells for the development of highly efficient therapeutic cancer vaccines.


Assuntos
Óxido de Alumínio/uso terapêutico , Nanopartículas/uso terapêutico , Neoplasias/prevenção & controle , Proteínas Ubiquitinadas/uso terapêutico , Óxido de Alumínio/química , Óxido de Alumínio/imunologia , Animais , Autofagossomos/imunologia , Linhagem Celular Tumoral , Células Dendríticas/citologia , Células Dendríticas/imunologia , Feminino , Proteínas Imobilizadas/química , Proteínas Imobilizadas/imunologia , Proteínas Imobilizadas/uso terapêutico , Camundongos Endogâmicos BALB C , Nanopartículas/química , Neoplasias/imunologia , Fagocitose , Proteínas Ubiquitinadas/química , Proteínas Ubiquitinadas/imunologia
5.
Lasers Surg Med ; 50(4): 280-283, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29214662

RESUMO

BACKGROUND: High concentrations of sub-micron nanoparticles have been shown to be released during laser hair removal (LHR) procedures. These emissions pose a potential biohazard to healthcare workers that have prolonged exposure to LHR plume. OBJECTIVE: We sought to demonstrate that cold sapphire skin cooling done in contact mode might suppress plume dispersion during LHR. METHODS: A total of 11 patients were recruited for laser hair removal. They were treated on the legs and axilla with a 755 or 1064 nm millisecond-domain laser equipped with either (i) cryogen spray (CSC); (ii) refrigerated air (RA); or (iii) contact cooling with sapphire (CC). Concentration of ultrafine nanoparticles <1 µm were measured just before and during LHR with the three respective cooling methods. RESULTS: For contact cooling (CC), counts remained at baseline levels, below 3,500 parts per cubic centimeter (ppc) for all treatments. In contrast, the CSC system produced large levels of plume, peaking at times to over 400,000 ppc. The CA cooled system produced intermediate levels of plume, about 35,000 ppc (or about 10× baseline). CONCLUSIONS: Cold Sapphire Skin cooling with gel suppresses plume during laser hair removal, potentially eliminating the need for smoke evacuators, custom ventilation systems, and respirators during LHR. Lasers Surg. Med. 50:280-283, 2018. © 2017 Wiley Periodicals, Inc.


Assuntos
Remoção de Cabelo/efeitos adversos , Terapia a Laser/efeitos adversos , Exposição Ocupacional/efeitos adversos , Saúde Ocupacional , Material Particulado/efeitos adversos , Adulto , Óxido de Alumínio/uso terapêutico , Estudos de Coortes , Feminino , Géis/uso terapêutico , Remoção de Cabelo/métodos , Humanos , Terapia a Laser/métodos , Masculino , Pessoa de Meia-Idade , Medição de Risco , Temperatura Cutânea , Adulto Jovem
6.
Acta Med Okayama ; 71(1): 41-47, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28238009

RESUMO

We investigated the long-term clinical results of total elbow arthroplasty (TEA) by cementless fixation of alumina ceramic unlinked elbow prostheses (J-alumina ceramic elbows: JACE) for the reconstruction of elbow joints with rheumatoid arthritis (RA). Seventeen elbows in 17 patients (aged 44-72 years, average 54.8) replaced by JACE TEA without bone cement were investigated. The average follow-up period was 10.7 (range, 1.0-19.3) years. Clinical conditions of each elbow before and after surgery were assessed according to the Mayo Elbow Performance Index (MEPI). Radiographic loosening was defined as a progressive radiolucent line of more than 1 mm that was completely circumferential around the intramedullary stem. The average MEPI significantly improved from 46.8 points preoperatively to 66.8 points at final follow-up (p=0.0226). However, aseptic loosening was noted in 10 of 17 elbows (58.8%) and revision surgery was required in 7 (41.2%). Most loosening was observed on the humeral side. With radiographic loosening and revision surgery defined as the end points, the likelihoods of prosthesis survival were 41.2% and 51.8%, respectively, up to 15 years by Kaplan-Meier analysis. The clinical results of JACE implantation without bone cement were disappointing, with high revision and loosening rates of the humeral component.


Assuntos
Óxido de Alumínio/uso terapêutico , Artrite Reumatoide/cirurgia , Artroplastia de Substituição do Cotovelo/métodos , Cimentação/métodos , Articulação do Cotovelo/cirurgia , Adulto , Idoso , Prótese de Cotovelo , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Medição da Dor , Próteses e Implantes , Falha de Prótese , Amplitude de Movimento Articular , Reoperação , Estudos Retrospectivos
7.
J Dent ; 57: 20-25, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27913279

RESUMO

OBJECTIVES: To compare the abrasive wear on human dentine in an in situ model associated with use of an experimental low abrasivity anti-sensitivity dentifrice containing 1% alumina and 5% sodium tripolyphosphate (STP) with an experimental ultra-low abrasivity non-alumina 5% STP dentifrice, a higher abrasivity daily-use whitening dentifrice, and water as controls. METHODS: This was a single-centre, single-blind, randomised, split-mouth, four-treatment, two-period, crossover in situ study in 29 healthy subjects. Subjects wore bilateral lower buccal appliances, each fitted with four dentine specimens. Study treatments were applied ex vivo (three times daily). Dentine loss was measured by non-contact profilometry after 5, 10 and 15days' treatment. RESULTS: All 29 subjects were included in the efficacy analysis. Significantly less dentine loss was associated with brushing with the low and ultra-low abrasivity dentifrices than with the higher abrasivity dentifrice at all timepoints (p<0.01). Brushing with ultra-low abrasivity dentifrice or water resulted in statistically significantly less dentine loss compared with brushing with the low abrasivity dentifrice at all timepoints (p<0.05). Dentine loss after brushing with ultra-low abrasivity dentifrice was not significantly different from brushing with water. CONCLUSIONS: The degree of dentine loss observed in this in situ model reflected the abrasivity of the study dentifrices. Brushing with low or ultra-low abrasivity STP-containing anti-sensitivity dentifrices resulted in significantly less dentine loss (equating to dentine wear) than with a higher abrasivity daily-use whitening dentifrice.


Assuntos
Esmalte Dentário/efeitos dos fármacos , Dentifrícios/uso terapêutico , Abrasão Dentária/tratamento farmacológico , Desgaste dos Dentes/tratamento farmacológico , Adulto , Óxido de Alumínio/farmacologia , Óxido de Alumínio/uso terapêutico , Estudos Cross-Over , Dentifrícios/química , Dentifrícios/farmacologia , Dentina/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polifosfatos/farmacologia , Polifosfatos/uso terapêutico , Método Simples-Cego , Fatores de Tempo , Erosão Dentária/tratamento farmacológico , Escovação Dentária/métodos , Cremes Dentais/farmacologia , Cremes Dentais/uso terapêutico , Adulto Jovem
8.
Molecules ; 21(6)2016 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-27338336

RESUMO

Aza-Michael reactions between primary aliphatic and aromatic amines and various Michael acceptors have been performed under environmentally-friendly solventless conditions using acidic alumina as a heterogeneous catalyst to selectively obtain the corresponding mono-adducts in high yields. Ethyl acrylate was the main acceptor used, although others such as acrylonitrile, methyl acrylate and acrylamide were also utilized successfully. Bi-functional amines also gave the mono-adducts in good to excellent yields. Such compounds can serve as intermediates for the synthesis of anti-cancer and antibiotic drugs.


Assuntos
Óxido de Alumínio/química , Aminas/química , Catálise , Ácidos/química , Acrilamida/química , Acrilatos/química , Acrilonitrila/química , Óxido de Alumínio/uso terapêutico , Aminas/uso terapêutico , Humanos , Inflamação/tratamento farmacológico , Neoplasias/tratamento farmacológico , Solventes
9.
Implant Dent ; 25(3): 394-9, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26990606

RESUMO

PURPOSE: To compare the tensile strength and marginal leakage of prefabricated abutments/copings, with or without surface sandblasting with aluminum oxide, luted with a calcium hydroxide-based temporary cement (CH, Dycal; Dentsply, Petrópolis, RJ, Brazil) or a noneugenol zinc oxide cement (ZO, Temp Bond NE; Kerr, Orange, CA). MATERIALS AND METHODS: A total of 48 CeraOne abutment analogs and respective copings were divided into 6 groups (n = 8) according to the component that was sandblasted: the coping only, coping + abutment or no sandblasting and the temporary cement used: CH or ZO. After cementation, the samples underwent 500 thermal cycles (5°C ± 2°C and 55°C ± 2°C) and were subsequently immersed in an aqueous solution of 0.5% basic fuchsine dye for 24 hours. Next, the tensile test was performed, and microleakage was assessed qualitatively. Data were analyzed using Mann-Whitney, Kruskal-Wallis tests, followed by the Student-Newman-Keuls test (α = 0.05). RESULTS: CH cement showed a tensile strength (245.6 N) significantly higher than that of the ZO (18.1 N). Sandblasting both abutment and coping increased tensile strength by 1.7 times. Marginal leakage was not influenced by sandblasting; however, CH presented less microleakage. CONCLUSION: Aluminum oxide sandblasting of the coping and abutment favored the tensile strength of temporary cements and the CH showed a higher tensile strength and less microleakage than did the ZO cement.


Assuntos
Dente Suporte , Cimentos Dentários/uso terapêutico , Infiltração Dentária/prevenção & controle , Retenção em Prótese Dentária , Óxido de Alumínio/uso terapêutico , Hidróxido de Cálcio/uso terapêutico , Projeto do Implante Dentário-Pivô , Prótese Dentária Fixada por Implante/métodos , Análise do Estresse Dentário , Eugenol/uso terapêutico , Minerais/uso terapêutico , Resistência à Tração , Óxido de Zinco/uso terapêutico
10.
J Dent Child (Chic) ; 83(3): 132-138, 2016 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-28327263

RESUMO

PURPOSE: Alumina air abrasion is an alternative for acid-etch technique for tooth preparation before placement of a fissure sealant. The aim of this study was to compare the retention of sealants placed subsequent to air abrasion with alumina and bioactive glass (BAG) particles. METHODS: Sixty-two 6-12 year old children were included in this study. Using a halfmouth design, the fissures were prepared using air abrasion with alumina particles on randomly assigned permanent mandibular or/and maxillary first molars on one side of the mouth (Group 1) and air abrasion with BAG on the contralateral side of the mouth (Group 2). Sealants were applied on 180 teeth, and were scored as missing, partially retained, and completely retained after three, six, nine and 12 months. Data were analyzed using Friedman and Wilcoxon tests (α=0.05). RESULTS: Sealant retention rates in the alumina group were higher than those in the BAG group at all time periods (P<0.001). CONCLUSIONS: Sealant retention after air abrasion with alumina particles was higher than BAG over 12 months.


Assuntos
Abrasão Dental por Ar/métodos , Óxido de Alumínio/uso terapêutico , Colagem Dentária/métodos , Vidro/química , Selantes de Fossas e Fissuras/uso terapêutico , Condicionamento Ácido do Dente/métodos , Óxido de Alumínio/química , Criança , Cárie Dentária/prevenção & controle , Esmalte Dentário/ultraestrutura , Falha de Restauração Dentária , Seguimentos , Humanos , Irã (Geográfico) , Microscopia Eletrônica de Varredura , Dente Molar/ultraestrutura , Selantes de Fossas e Fissuras/química , Propriedades de Superfície , Resultado do Tratamento
11.
J Clin Dent ; 26(4): 96-103, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26856015

RESUMO

OBJECTIVE: To evaluate the ability of two experimental desensitizing dentifrices, both containing a chemical cleaning agent, one with ultra-low abrasivity and one with low abrasivity, a standard fluoride dentifrice, and a daily-use whitening dentifrice to remove extrinsic tooth stain. METHODS: This was a single-center, examiner-blind, randomized, controlled, four-treatment, parallel-group study in healthy adults. Extrinsic stain was evaluated using the Macpherson modification of the Lobene Stain Index (MLSI). At baseline, eligible subjects with a total MLSI (area x intensity [A x I]) score of 15 for the facial surfaces of the 12 anterior teeth were stratified (based on total MLSI [A x I] score [< 45 = low; ≥ 45 = high] and smoking status) and randomized to treatment with one of four dentifrices: an experimental ultra-low abrasivity desensitizing dentifrice (relative dentin abrasion [RDA] -12); an experimental low abrasivity desensitizing dentifrice (RDA -40); a standard fluoride dentifrice with moderate abrasivity (RDA -80); and a whitening dentifrice with higher abrasivity (RDA -142). Both desensitizing dentifrices contained 5% potassium nitrate and 5% sodium tripolyphosphate (a chemical cleaning agent). Treatment effects were evaluated after four and eight weeks of twice-daily brushing. RESULTS: In total, 142 subjects were randomized and 133 subjects completed the study. All study dentifrices demonstrated statistically significant reductions in extrinsic tooth stain from baseline after four and eight weeks of twice-daily use (p < 0.01). There were no statistically significant between-treatment differences for the primary variable (mean MLSI [A x I] score across all assessed sites) at four or eight weeks, and no notable trends were observed. CONCLUSION: All study dentifrices reduced extrinsic tooth stain. The experimental ultra-low and low abrasivity desensitizing dentifrices containing 5% sodium tripolyphosphate performed similarly to both a moderate abrasivity standard fluoride dentifrice and a higher abrasivity whitening dentifrice.


Assuntos
Dentifrícios/uso terapêutico , Polifosfatos/uso terapêutico , Descoloração de Dente/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Óxido de Alumínio/uso terapêutico , Cariostáticos/uso terapêutico , Dente Canino/efeitos dos fármacos , Dessensibilizantes Dentinários/uso terapêutico , Feminino , Humanos , Incisivo/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Nitratos/uso terapêutico , Compostos de Potássio/uso terapêutico , Método Simples-Cego , Fluoreto de Sódio/uso terapêutico , Clareadores Dentários/uso terapêutico , Descoloração de Dente/classificação , Resultado do Tratamento , Adulto Jovem
12.
Full dent. sci ; 5(20): 584-589, jul.-set. 2014. ilus, tab, graf
Artigo em Português | LILACS, BBO - Odontologia | ID: lil-737447

RESUMO

Este trabalhou avaliou a adaptação marginal de infraestruturas cerâmicas (copings em alumina) de dois sistemas cerâmicos livres de metal. Foram pesquisados os sistemas In-Ceram e Procera. Os valores de discrepância vertical presentes entre as margens de nove copings de cada sistema cerâmico e a margem de um modelo mestre metálico foram medidos com microscópio eletrônico de varredura em 5 pontos de cada infraestrutura. Esses valores foram medidos em micrômetros (pm). Os resultados foram analisados estatisticamente com o software SPSS (Statistical Package for the Social Sciences 11.0), através do teste t de Student, considerando-se significativos os valores de p<0(05. Os valores médios de discrepância marginal dos dois sistemas, medidos em microscópio eletrônico de varredura, mostraram diferença estatística entre si (p=0,001), sendo observadas desadaptações de 39±11pm (sistemas Procera) e 11 5±56pm (sistema In-Ceram). Conclui-se que os dois sistemas cerâmicos livres de metal avaliados apresentaram adaptação marginal dentro de limites aceitáveis clinicamente.


This work has evaluated the marginal fit of alumina copings of two metal free ceramic systems, namely Procera and In-Ceram systems. The marginal fit values of the margins in nine copings of each ceramic system and in a metal master model were assessed using electron- scanning microcopy in five points of the margin of each coping. Such values were measured in micrometers (pm). The results were analyzed statistically by the SPSS software (p<0.05). The marginal fit mean values for both systems have presented statistical difference (p=0.001), being of 39±11 pm and 115±56pm for the Procera and Inc-Ceram systems, respectively. Both systems have presented marginal fit according to the clinical acceptance.


Assuntos
Cerâmica/uso terapêutico , Adaptação Marginal Dentária , Materiais Dentários , Óxido de Alumínio/uso terapêutico , Interpretação Estatística de Dados , Microscopia Eletrônica
13.
Intern Med J ; 44(6): 615-7, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24946820

Assuntos
Anti-Inflamatórios/uso terapêutico , Cistite/tratamento farmacológico , Hematúria/tratamento farmacológico , Imunossupressores/uso terapêutico , Metilprednisolona/uso terapêutico , Lesões por Radiação/tratamento farmacológico , Óxido de Alumínio/uso terapêutico , Anti-Inflamatórios/administração & dosagem , Anticorpos Monoclonais Murinos/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Transfusão de Sangue , Terapia Combinada , Ciclofosfamida/administração & dosagem , Cistite/etiologia , Cistite/imunologia , Cistite/terapia , Doxorrubicina/administração & dosagem , Estrogênios/uso terapêutico , Etoposídeo/administração & dosagem , Hidratação , Hematúria/etiologia , Hematúria/imunologia , Hematúria/terapia , Humanos , Oxigenoterapia Hiperbárica , Imunossupressores/administração & dosagem , Irradiação Linfática/efeitos adversos , Metástase Linfática/radioterapia , Linfoma de Célula do Manto/complicações , Linfoma de Célula do Manto/tratamento farmacológico , Linfoma de Célula do Manto/radioterapia , Masculino , Metilprednisolona/administração & dosagem , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Lesões por Radiação/etiologia , Lesões por Radiação/imunologia , Radioterapia Conformacional/efeitos adversos , Recidiva , Rituximab , Terapia de Salvação/efeitos adversos , Vincristina/administração & dosagem
14.
J Bone Joint Surg Am ; 95(12): 1088-93, 2013 Jun 19.
Artigo em Inglês | MEDLINE | ID: mdl-23783205

RESUMO

BACKGROUND: We asked whether cementless total hip arthroplasties that made use of alumina-on-highly cross-linked polyethylene bearings would improve hip score and functional activity and reduce the prevalence of polyethylene wear, osteolysis, and aseptic loosening. METHODS: Consecutive primary total hip arthroplasties were performed in fifty patients (a total of sixty hips among thirty-four men and sixteen women) who were younger than thirty years of age. The average age at the time of the index arthroplasty was 28.3 years (range, twenty-one to twenty-nine years). The average follow-up was 10.8 years (range, ten to twelve years). Osteolysis and polyethylene wear rates were evaluated with use of radiography and computed tomography. RESULTS: The mean Harris hip score, which was 38 points (range, 6 to 45 points) preoperatively, had improved to 95 points (range, 85 to 100 points) at a mean follow-up time of 10.8 years. The mean penetration (and standard error of the mean) of the polyethylene liner was 0.031 ± 0.004 mm per year. No hip had osteolysis or aseptic loosening. CONCLUSIONS: At a minimum of ten years and an average of 10.8 years postoperatively, the current generation of cementless acetabular and femoral components with alumina-on-highly cross-linked polyethylene bearings was functioning well and was not associated with the development of osteolysis in our group of patients younger than thirty years of age. While the long-term prevalence of polyethylene wear and osteolysis remains unknown, the midterm data are promising.


Assuntos
Artroplastia de Quadril/instrumentação , Prótese de Quadril , Osteólise/etiologia , Polietileno/uso terapêutico , Falha de Prótese/etiologia , Atividades Cotidianas , Adulto , Óxido de Alumínio/uso terapêutico , Artroplastia de Quadril/métodos , Artroplastia de Quadril/reabilitação , Feminino , Seguimentos , Humanos , Artropatias/diagnóstico por imagem , Artropatias/reabilitação , Artropatias/cirurgia , Masculino , Osteólise/diagnóstico por imagem , Osteólise/reabilitação , Desenho de Prótese , Tomografia Computadorizada por Raios X , Resultado do Tratamento
15.
Int J Oral Maxillofac Surg ; 41(5): 616-23, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22137335

RESUMO

The purpose of this study was to investigate the relationship between the root apex of the upper incisors and neighbouring anatomical structures as well as the morphology of the root-end foramen after apicoectomy. Fifty-seven patients requiring endodontic surgical treatment for a maxillary anterior root were enrolled. A preoperative diagnostic computed tomography (CT) scan was analysed to determine: the distance between the anterior wall of the nasopalatine duct and the central (CI-ND) incisor root 4mm from the apex; and the distance between the floor of the nasal cavity and the tip of either the central (CI-NF) or the lateral (LI-NF) incisor root. After apicoectomy, root-end foramen endoscopic pictures were taken in order to characterize their morphology. Fifty-nine central and 26 lateral incisors were evaluated. The average CI-ND was 4.71 ± 1.26 (SD) mm. The average CI-NF was 10.62 ± 2.25 mm. The average LI-NF was 13.05 ± 2.43 mm. The foramen shape after apicoectomy was ovoid to circular in about 90% of cases in both central and lateral incisors. A sound knowledge of the anatomical relationships at the surgical site is essential for the clinician to perform a safe endodontic surgical procedure.


Assuntos
Incisivo/anatomia & histologia , Maxila/anatomia & histologia , Cavidade Nasal/anatomia & histologia , Palato Duro/anatomia & histologia , Ápice Dentário/anatomia & histologia , Raiz Dentária/anatomia & histologia , Óxido de Alumínio/uso terapêutico , Apicectomia/instrumentação , Apicectomia/métodos , Curetagem/métodos , Cimentos Dentários/uso terapêutico , Endoscopia/métodos , Feminino , Humanos , Imageamento Tridimensional/métodos , Incisivo/diagnóstico por imagem , Masculino , Maxila/diagnóstico por imagem , Cavidade Nasal/diagnóstico por imagem , Osteotomia/métodos , Palato Duro/diagnóstico por imagem , Doenças Periapicais/terapia , Radiografia Interproximal , Obturação Retrógrada/métodos , Materiais Restauradores do Canal Radicular/uso terapêutico , Retalhos Cirúrgicos , Tomografia Computadorizada por Raios X/métodos , Ápice Dentário/diagnóstico por imagem , Raiz Dentária/diagnóstico por imagem , Dente não Vital/terapia , Óxido de Zinco/uso terapêutico
16.
Chir Narzadow Ruchu Ortop Pol ; 76(1): 14-20, 2011.
Artigo em Polonês | MEDLINE | ID: mdl-21850992

RESUMO

INTRODUCTION: The aim of the study was a preliminary report of the use of large diameter alumina femoral heads in total hip arthroplasty. MATERIAL AND METHODS: In the years 2005-2008 50 THRs were implanted in 48 patients with the use of 36 mm alumina femoral heads. 5 women and 43 men in the age from 35 to 75 years (average 61 years) were operated on. Primary osteoarthritis was the cause of 41 arthroplasties, and AVN of femoral head of 9 surgeries. 18 alumina/alumina and 32 polyethylene/alumina THRs were implanted. The prospective study consisted of clinical examination with Harris Hip Score and X-ray evaluation. AP and lateral view X-rays were evaluated. The incidence of radiolucent lines around acetabular cups were noted with DeLee and Charnley zones and around stems with Gruen's zones. RESULTS: The follow up is from 24 to 58 months (average 40 months). There was an increase in Harris Hip Score from average 37 points (from 25 to 49 points) before operation to average 94 points (from 90 to 100 points) after the surgery. The incidence of postoperative dislocation have not been noted. Long-term postoperative X-ray examination have showed proper geometry of endoprostheses without radiolucent lines. Neither visible wear of bearing surfaces nor breakage of alumina components have been noted. CONCLUSIONS: 1) The use of 36 mm femoral heads in total hip arthroplasty decrease the risk of postoperative dislocation. 2) Innovative biomaterials: alumina ceramics and cross-linked polyethylene give chance for decrease the incidence of osteolysis.


Assuntos
Óxido de Alumínio/uso terapêutico , Artroplastia de Quadril/métodos , Prótese de Quadril , Polietileno , Desenho de Prótese/métodos , Adulto , Idoso , Materiais Revestidos Biocompatíveis/uso terapêutico , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ajuste de Prótese , Estresse Mecânico , Propriedades de Superfície
17.
Rev. bras. odontol ; 68(1): 81-84, jan.-jun. 2011. ilus, tab
Artigo em Português | LILACS, BBO - Odontologia | ID: lil-642780

RESUMO

O objetivo deste trabalho é apresentar um caso de fechamento de diastema com coroas de alumina densamente sinterizadas através da utilização do Sistema Procera®, mostrando as etapas de confecção e requisitos técnicos para o sucesso dos casos. O caso apresentado seguiu o seguinte protocolo clínico: enceramento diagnóstico, confecção de preparo comtérmino em chanfro e desgaste de 1,5mm nas paredes axiais e 2,0mm de desgaste incisal, confecção de restaurações provisórias, moldagem com técnica de duplo fio de afastamento, enceramento das subestruturas para duplo escaneamento, aplicação cerâmica e cimentação por meio de cimento resinoso. Os resultados obtidos foram julgados como bastante satisfatórios pela paciente e pelo profissional responsável sob os pontos de vista estéticos e biológicos.


Assuntos
Humanos , Feminino , Coroa do Dente , Diastema/terapia , Resultado do Tratamento , Óxido de Alumínio/uso terapêutico , Satisfação do Paciente
18.
Oral Maxillofac Surg ; 15(3): 153-9, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21537920

RESUMO

PURPOSE: The main purpose of this retrospective cohort study was to evaluate the 4-year success rate of endodontic surgery in combination with a collagen resorbable membrane for the treatment of through-and-through periradicular lesions. MATERIALS AND METHODS: Patients with one or more teeth with a through-and-through periradicular lesion in need of endodontic surgery were treated. A clinical and radiographic evaluation was performed at 3, 6, 12, 24, 36, and 48 months. The outcome was categorized at 1 and 4-year follow-up as success, failure, and doubtful depending on clinical signs and symptoms and radiographic evaluation. Fisher's exact test was used to evaluate differences between successful and failed cases (P < 0.05). RESULTS: Forty-three teeth in 33 patients were radiographically and clinically evaluated after 4 years. Thirty-eight teeth were classified as success, 4 teeth as failure, and 1 tooth as doubtful. No statistically significant differences were found in results related to tooth type, tooth location, and presence of post. CONCLUSIONS: The association of endodontic surgery and guided tissue regeneration for the treatment of through-and-through periapical lesions leads to excellent outcomes up to 4 years. Standardized criteria are needed to determine the treatment outcome.


Assuntos
Apicectomia/métodos , Regeneração Tecidual Guiada Periodontal/métodos , Doenças Periapicais/cirurgia , Implantes Absorvíveis , Adulto , Óxido de Alumínio/uso terapêutico , Apicectomia/instrumentação , Transplante Ósseo , Estudos de Coortes , Colágeno , Cimentos Dentários/uso terapêutico , Feminino , Seguimentos , Humanos , Masculino , Membranas Artificiais , Radiografia Interproximal , Obturação Retrógrada/instrumentação , Obturação Retrógrada/métodos , Estudos Retrospectivos , Materiais Restauradores do Canal Radicular/uso terapêutico , Resultado do Tratamento , Procedimentos Cirúrgicos Ultrassônicos/instrumentação , Cicatrização/fisiologia , Óxido de Zinco/uso terapêutico
19.
Am J Dent ; 23(4): 196-200, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21250568

RESUMO

PURPOSE: To determine whether natural smoking stain could be removed/inhibited effectively by a toothpaste containing 5% d-limonene. For comparison and contrast, the effects of d-limonene on tea stain were also assessed. METHODS: The design was a randomized controlled double-blind trial with parallel groups. Toothpastes were: A: positive control with perlite whitening formulation; B: A+5% d-limonene; C: D + 5% d-limonene; D: negative control. The extrinsic stains were measured using Lobene Stain Index. Following baseline examination, all subjects were randomly assigned to one of the four toothpaste groups and instructed to brush with the assigned products twice daily. Subjects returned to the clinic after 4-week brushing for stain removal assessment, then all extrinsic stains, plaque and supragingival calculus were removed and use of assigned products was continued for another 4 weeks, and the stain scores were repeated for inhibition assessment. RESULTS: A total of 408 subjects, 201 with smoking stains and 207 with tea stains, participated in the trial. 5% d-limonene combined with Perlite whitening formulation significantly reduced stain scores both for smoking stain removal and inhibition (P < 0.05). Furthermore, 5% d-limonene alone (in negative formulation) exhibited an additional advantage for smoking stain inhibition (P < 0.05), but the advantage was not found for long-standing smoking stain removal (P > 0.05). The additional advantage of 5% d-limonene was shown neither for removal nor for inhibition in the tea stain study (P > 0.05). All test products were well tolerated over the study period.


Assuntos
Cicloexenos/uso terapêutico , Fumar/efeitos adversos , Terpenos/uso terapêutico , Clareadores Dentários/uso terapêutico , Descoloração de Dente/terapia , Cremes Dentais/uso terapêutico , Adulto , Idoso , Óxido de Alumínio/uso terapêutico , Química Farmacêutica , Cicloexenos/administração & dosagem , Profilaxia Dentária , Método Duplo-Cego , Feminino , Humanos , Limoneno , Masculino , Pessoa de Meia-Idade , Dióxido de Silício/uso terapêutico , Chá/efeitos adversos , Terpenos/administração & dosagem , Clareadores Dentários/administração & dosagem , Descoloração de Dente/etiologia , Descoloração de Dente/prevenção & controle , Cremes Dentais/administração & dosagem
20.
Arch Orthop Trauma Surg ; 129(9): 1145-50, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18568354

RESUMO

Improvements of ceramic components and design changes have reduced failure rates over the past 30 years in total hip arthroplasty. We present a series of n = 11 cases with ceramic failure out of n = 113 implantations, from which n = 66 were ceramic-on-ceramic (n = 50 with ceramic insert with sandwich in polyethylene and n = 16 with directly fixed ceramic inlay) and n = 47 ceramic on polyethylene bearings, between 1999 and 2001 after introduction of a new implantation system to the market. The overall fracture rate of ceramic for the whole series (n = 113) was 9.7%. For the combination ceramic head with UHMW-PE (n = 47) the fracture rate was 2.1%. For the combination ceramic with ceramic (n = 66) the fracture rate was 15.2%. For the combination ceramic with ceramic sandwich in PE (n = 50) the failure rate was 18%. Only three patients experienced a trauma. Demography of patients (age, gender, body weight and BMI) was not statistically different between patients with failed ceramics and the rest of the patients making patient-specific risk factors unlikely to be an explanation for the failures. Retrospective X-ray analysis of the cup positioning did not show significant difference between failed and non-failed implants in terms of mean cup inclination and version making also operation-specific factors unlikely to be the only reason of this high failure rate. Therefore, manufacturer-specific factors such as design features may have contributed to this high failure rate. Further analysis of the whole series with biomechanical testing of the retrieved material needs to be performed.


Assuntos
Acetábulo/cirurgia , Prótese de Quadril , Polietilenos/uso terapêutico , Falha de Prótese , Óxido de Alumínio/uso terapêutico , Fenômenos Biomecânicos , Análise de Falha de Equipamento , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Desenho de Prótese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA